Cel AI PLC (LON: CLAI)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.0550
-0.0050 (-8.33%)
Dec 23, 2024, 1:10 PM BST
-87.78%
Market Cap 361.35K
Revenue (ttm) 54.16K
Net Income (ttm) -2.11M
Shares Out 602.25M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,852
Open 0.0562
Previous Close 0.0600
Day's Range 0.0550 - 0.0650
52-Week Range 0.0300 - 0.8000
Beta -1.60
Analysts n/a
Price Target n/a
Earnings Date Dec 20, 2024

About Cel AI

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom. [Read more]

Founded 2018
Employees 5
Stock Exchange London Stock Exchange
Ticker Symbol CLAI
Full Company Profile

Financial Performance

In 2023, Cel AI's revenue was 67,236, an increase of 132.62% compared to the previous year's 28,904. Losses were -3.31 million, -44.75% less than in 2022.

Financial Statements

News

There is no news available yet.